BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20138860)

  • 21. Analysis of the MMP-9 (C-1562 T) and TIMP-2 (G-418C) gene promoter polymorphisms in patients with chronic periodontitis.
    de Souza AP; Trevilatto PC; Scarel-Caminaga RM; de Brito RB; Barros SP; Line SR
    J Clin Periodontol; 2005 Feb; 32(2):207-11. PubMed ID: 15691353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional polymorphisms in ACE and CYP11B2 genes and atrial fibrillation in patients with hypertensive heart disease.
    Huang M; Gai X; Yang X; Hou J; Lan X; Zheng W; Chen F; He J
    Clin Chem Lab Med; 2009; 47(1):32-7. PubMed ID: 19117407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Lacchini R; Gerlach RF; Passos CJ; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2011 Sep; 409(20):4242-6. PubMed ID: 21794897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm.
    Saracini C; Bolli P; Sticchi E; Pratesi G; Pulli R; Sofi F; Pratesi C; Gensini GF; Abbate R; Giusti B
    J Vasc Surg; 2012 Jan; 55(1):171-179.e2. PubMed ID: 22094117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological significance of MMP-2 and TIMP-2 genotypes in gastric cancer.
    Wu CY; Wu MS; Chen YJ; Chen CJ; Chen HP; Shun CT; Chen GH; Huang SP; Lin JT
    Eur J Cancer; 2007 Mar; 43(4):799-808. PubMed ID: 17236757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinase-2 -735C/T polymorphism is associated with resistant hypertension in a specialized outpatient clinic in Brazil.
    Sabbatini AR; Barbaro NR; de Faria AP; Ritter AMV; Modolo R; Correa NB; Brunelli V; Pinho C; Fontana V; Moreno H
    Gene; 2017 Jul; 620():23-29. PubMed ID: 28390988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease.
    Marson BP; Lacchini R; Belo V; Dickel S; da Costa BP; Poli de Figueiredo CE; Tanus-Santos JE
    Am J Nephrol; 2012; 35(3):209-15. PubMed ID: 22302011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensinogen polymorphisms and acquired atrial fibrillation in Chinese.
    Wang QS; Li YG; Chen XD; Yu JF; Wang J; Sun J; Lu SB; Jin L; Wang XF
    J Electrocardiol; 2010; 43(4):373-7. PubMed ID: 19932491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting.
    Marín F; Pascual DA; Roldán V; Arribas JM; Ahumada M; Tornel PL; Oliver C; Gómez-Plana J; Lip GY; Valdés M
    Am J Cardiol; 2006 Jan; 97(1):55-60. PubMed ID: 16377284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    Mukherjee R; Herron AR; Lowry AS; Stroud RE; Stroud MR; Wharton JM; Ikonomidis JS; Crumbley AJ; Spinale FG; Gold MR
    Am J Cardiol; 2006 Feb; 97(4):532-7. PubMed ID: 16461051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the correlation between CETP TaqIB, KCNE1 S38G and eNOS T-786C gene polymorphisms for predisposition and non-valvular atrial fibrillation].
    Xu LX; Yang WY; Zhang HQ; Tao ZH; Duan CC
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 May; 29(5):486-92. PubMed ID: 18956684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
    Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene polymorphisms of matrix metalloproteinase-2, -9 and -12 in periodontal health and severe chronic periodontitis.
    Gürkan A; Emingil G; Saygan BH; Atilla G; Cinarcik S; Köse T; Berdeli A
    Arch Oral Biol; 2008 Apr; 53(4):337-45. PubMed ID: 18155181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India.
    Srivastava P; Lone TA; Kapoor R; Mittal RD
    Arch Med Res; 2012 Feb; 43(2):117-24. PubMed ID: 22374248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas.
    Coven İ; Ozer O; Ozen O; Şahin Fİ; Altinors N
    J Neurosurg; 2014 Dec; 121(6):1478-82. PubMed ID: 25259564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.